In a report released today, Charles Pitman CFA from Barclays maintained a Buy rating on UCB SA (0NZT – Research Report), with a price target of €240.00. The company’s shares closed last ...

Stats SA has recently addressed concerns over rumours circulating on social media, suggesting that scammers are posing as official field agents. The agency reached out to the Newcastle Advertiser ...

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF ...

“We got denied. Cancelled. Our order was cancelled because our logo includes the phrase ‘conservative women.’” Some Instagram users came to the organization’s defense in the comment ...

Tuesday, UBS increased its stock price target on UCB (UCB:BB) (OTC: UCBJY) to EUR135.00 from EUR125.00, while keeping a Buy rating ...

Investing.com – Belgium stocks were higher after the close on Monday, as gains in the Healthcare, Utilities and Banking sectors ...

Barclays analyst Charles Pitman CFA reiterated a Buy rating on UCB SA (0NZT – Research Report) today and set a price target of €240.00. The company’s shares closed last Friday at €166.40.

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Investing.com – Belgium equities were higher at the close on Thursday, as gains in the Telecoms, Technology and Healthcare sectors ...

Investing.com – Belgium equities were lower at the close on Tuesday, as losses in the Consumer Goods, Basic Materials and ...